Literature DB >> 31317874

Facial involvement in Indian psoriatic patients and its association with disease severity and metabolic syndrome: A cross-sectional study.

P S S Ranugha1, Priya Bishnoi2, Laxmisha Chandrashekar3.   

Abstract

BACKGROUND: Face was often thought to be spared in psoriasis possibly due to the protective effect of sebum and low-dose ambient ultraviolet radiation exposure. Some have suggested that facial involvement is common and indicates disease severity. There is a paucity of data on this, particularly from India. Psoriatics have a higher prevalence of metabolic syndrome, and patients with severe disease are at greater risk.
OBJECTIVE: A study of the frequency and type of facial involvement in Indian psoriatic patients and its association with disease severity and metabolic syndrome.
METHODS: A total of 250 consecutive psoriatic patients were screened and these yielded 188 patients with facial involvement. Facial psoriatics were divided into peripherofacial, centrofacial and mixed facial types. Disease severity was assessed using whole body, scalp, facial psoriasis area severity index scores and nail area psoriasis severity index scores. Patients were evaluated for the presence of metabolic syndrome using NCEP-III criteria. All parameters were compared both between facial and nonfacial psoriatics and between cases with different types of face involvement.
RESULTS: The mean age (P = 0.04) and age of onset of disease (P = 0.02) was lower and median whole-body psoriasis area severity index score was higher in psoriatics with facial involvement (P < 0.001) than those without. No significant association was found between facial involvement and metabolic syndrome. Mixed facial was the commonest type of facial involvement and there was a significant association of mixed facial involvement with increased total body psoriasis area severity index scores (P < 0.001). LIMITATIONS: Dietary habits, physical activity level, family history of diabetes and obesity were not enquired for in our patients. Centrofacial cases were too few in number, hence statistical comparisons are not relevant.
CONCLUSION: Facial involvement in psoriatics is associated with severe disease but not metabolic syndrome. Mixed facial type might be considered a marker of overall psoriasis disease severity in the Indian population.

Entities:  

Keywords:  Disease severity; facial involvement; metabolic syndrome; psoriasis

Mesh:

Year:  2021        PMID: 31317874     DOI: 10.4103/ijdvl.IJDVL_655_18

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN: 0378-6323            Impact factor:   2.545


  19 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

2.  Facial involvement in Iranian psoriatic patients and its relation to severity of the disease.

Authors:  S Rassai; A Feily; N Sina; A Hajikaramian
Journal:  J Eur Acad Dermatol Venereol       Date:  2010-12       Impact factor: 6.166

3.  Facial psoriasis.

Authors:  P V Harrison; G B Walker
Journal:  Clin Exp Dermatol       Date:  1985-01       Impact factor: 3.470

4.  Facial sparing in psoriasis.

Authors:  J D Bernhard
Journal:  Int J Dermatol       Date:  1983-06       Impact factor: 2.736

5.  Severe psoriasis--oral therapy with a new retinoid.

Authors:  T Fredriksson; U Pettersson
Journal:  Dermatologica       Date:  1978

6.  Classification of facial psoriasis based on the distributions of facial lesions.

Authors:  Seung Man Woo; Jung Won Choi; Hyun Sun Yoon; Seong Jin Jo; Jai Il Youn
Journal:  J Am Acad Dermatol       Date:  2008-03-21       Impact factor: 11.527

7.  Clinical characteristics of patients with facial psoriasis in Malaysia.

Authors:  Sharifah Rosniza Syed Nong Chek; Suganthy Robinson; Azura Mohd Affandi; Nurakmal Baharum
Journal:  Int J Dermatol       Date:  2016-04-07       Impact factor: 2.736

Review 8.  Psoriasis and the metabolic syndrome.

Authors:  Paolo Gisondi; Anna Chiara Fostini; Irene Fossà; Giampiero Girolomoni; Giovanni Targher
Journal:  Clin Dermatol       Date:  2017-09-08       Impact factor: 3.541

Review 9.  Metabolic syndrome: definitions and controversies.

Authors:  Eva Kassi; Panagiota Pervanidou; Gregory Kaltsas; George Chrousos
Journal:  BMC Med       Date:  2011-05-05       Impact factor: 8.775

10.  An update on psoriasis and metabolic syndrome: A meta-analysis of observational studies.

Authors:  Sanminder Singh; Paulina Young; April W Armstrong
Journal:  PLoS One       Date:  2017-07-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.